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Abstract
Background: Cancer has been one of the leading causes of mortality in this era. Ruta angustifolia L. Pers has been
traditionally used as an abortifacient, antihelmintic, emmenagogue and ophthalmic. In Malaysia and Singapore, the
local Chinese community used it for the treatment of cancer.
Methods: In this study, the methanol and fractionated extracts (hexane, chloroform, ethyl acetate and water) of R.
angustifolia were tested for its cytotoxicity using the sulforhodamide (SRB) cytotoxicity assay against HCT-116, A549,
Ca Ski and MRC5 cell lines. Chemical isolation was carried out by using the high performance liquid chromatography
(HPLC) and the isolated compounds were tested for its cytotoxicity against A549 cell line. Cellular and nuclear
morphological changes were observed in the cells using phase contrast microscopy and Hoechst/PI fluorescent
staining. The externalisation of phosphatidylserine was observed through FITC-labelling Annexin V/PI assay whilst DNA
fragmentation was observed through the TUNEL assay. Other indication of apoptosis occuring through the
mitochondrial pathway were the attenuation of mitochondrial membrane potential and increase in ROS
production. Activation of caspase 9 and 3 were monitored. Western blot analysis was done to show the
expression levels of apoptotic proteins.
Results: The chloroform extract (without chlorophyll) exhibited the highest cytotoxic activity with IC50 of 10.1
± 0.15 μg/ml against A549 cell line. Further chemical investigation was thus directed to this fraction which led
to the isolation of 12 compounds identified as graveoline, psoralen, kokusaginine, methoxysalen, bergapten,
arborinine, moskachan B, chalepin, moskachan D, chalepensin, rutamarin and neophytadiene. Among these
compounds, chalepin exhibited excellent cytotoxicity against A549 cell line with an IC50 value of 8.69 ± 2.43 μg/ml
(27.64 μM). In western blot analysis, expression of p53, truncated Bid, Bax and Bak while the anti-apoptotic proteins
Bcl-2, survivin, XIAP, Bcl-XL,cFLIP decreased in a time-dependent manner when A549 cells were treated with
36 μg/ml of chalepin. In addition, the level of PARP was found to decrease.
Conclusion: Hence these findings indicated that chalepin-induced cell death might involve the intrinsic
mitochodrial pathway resulting in the upregulation of pro-apoptotic proteins and downregulation of anti-apoptotic
proteins. Thus, chalepin could be an excellent candidate for the development of an anticancer agent.
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Background
Lung cancer has the largest number of fatality and com-
plications in comparison to other types of cancer. There
are mainly two types of lung cancer i.e., the small cell
lung cancer and the non-small cell lung cancer. According
to the National Cancer Institute, US, tabacco smoking is
the most common cause of lung cancer. In Malaysia, lung
cancer is reported as the most common killer among ma-
lignancies with an estimated annual incidence of 30,000
[1]. It is noteworthy that, the current treatment for lung
cancer does not cure the disease.
Cells undergoing apoptosis are characterised by cell
shrinkage, blebbing of plasma membrane, and mainten-
ance of organelle integrity, chromatin condensation and
fragmentation of DNA, followed by programmed re-
moval of dead cells by phagocytes. It is like a “suicide”
program but does not cause any damage to the sur-
rounding tissues. Apoptosis has been subclassified into
two types of death pathways, namely, the extrinsic path-
way and the mitochondria-mediated pathway [2]. All
pathways of apoptosis converge upon the activation of
caspases, which are a family of cysteine proteases that
orchestrate the efficient and non-inflammatory demoli-
tion of cells. Two main pathways leading to caspase acti-
vation have been well characterized: the extrinsic route
initiated by cell surface receptors leading directly to cas-
pase 8 activation, and the intrinsic path that is regulated
by the mitochondria [3].
Natural products has been a great success in our soci-
ety with the usage of plant and microbial secondary me-
tabolites in reducing ailments. The use of plant and
microbial secondary metabolites has helped in doubling
our life span in the 20th century. Since their chemical
diversity is based on biological and geographical diver-
sity, the entire globe is explored for bioprospecting by
researchers [4].
Ruta angustifolia L. Pers. is a medicinal plant which
originates from Southern Europe and North Africa. It
grows up in the mountains to an elevation of 1,000 m
above sea level. The plant often grows up to 1.5 m
height with slender woody stems and light green leaves.
The flowering period is normally between April to July.
The plant has yellow flowers which gives off a very
strong foetid odour. The plant reproduces via seeds and
also grows from stem cuttings.
Ruta angustifolia is locally known as ‘garuda’ or ‘sadal’
in Malaysia, ‘inggu’, ‘godong minggu’ or ‘aruda’ in
Indonesia, Rue in English and ‘luru’ in Vietnam. It is
used for medicinal and culinary purposes since ancient
times. Ruta angustifolia is not native to Southeast Asia
but has been introduced here. The plant normally grows
in mountainous areas i.e., about 1000 m above sea level.
Besides that, it is also cultivated as a pot plant in
Malaysia and occasionally in Vietnam and Java for
medicinal purposes. The plant’s decoction is commonly
used to cure cramps, flatulence and fever. In Indonesia,
R. angustifolia has been known as traditional medicine
for liver disease and jaundice. It has been reported to
contain coumarin, alkaloid and flavonoid compounds
[5]. The extracts of Ruta angustifolia (ethanol, hexane,
dichloromethane and methanol) were recently reported
to exhibit anti-viral activity. It exhibited anti-viral activ-
ity against hepatoma cell line (Huh7.5) with IC50 values
ranging between 1.6 to 15.6 μg/ml [5]. Besides that, iso-
lated compounds from the methanol extract of the roots
and aerial parts of Ruta graveolens which is another
species of Ruta species, stimulated inhibition of platelet
aggregation property and exhibited cytotoxicity against se-
lected cancer cell lines such as colon, lung and cervical
cancers [6]. These may suggest that the extracts of R.
angustifolia may possess cytotoxicity. Other than that,
extracts of leaves of Ruta angustifolia was found to
be commonly used by the chinese community in
Malaysia and Singapore in treatment of cancer (per-
sonal communication).
There are several earlier studies that has been reported
for Ruta angustifolia. In 1986, Del Castillo [7] isolated
angustifolin, a coumarin, from this plant and in 1966, a
new shikimate metabolite was found from the aerial
parts of Ruta angustifolia. These compounds were iden-
tified as moskachan A,B,C and D. In another study, cha-
lepin and pseudane IX isolated from Ruta angustifolia
was found to stop the replication of hepatitis C virus [5].
Up to date, there is no report on chalepin as a thera-
peutic agent for cancer. It is therefore of interest to
study on the capability of chalepin to induce apoptosis.
Methods
Source of plant material
The whole plant of Ruta angustifolia L. Pers was ob-
tained from a plant nursery near Sungai Buloh, Se-
langor, Malaysia. The plant was identified by Slamet
Wahyono from the Research Station of Medicinal
Plant and Traditional Medicine Research and Develop-
ment Centre, Tawangmangu, Central Java, Indonesia. A
voucher specimen numbered KLU48128 was deposited at
the Herbarium of the Institute of Biological Sciences, Fac-
ulty of Science, University of Malaya on 26th April 2014.
Preparation of plant extracts
Preparation of the methanol extracts and its fractionated
extracts
The leaves of the plant were separated, washed and dried
in an oven at a constant temperature of 50 °C for 3 days.
The dried leaves were then ground using a commercial
blender to a fine powder. The powdered leaves (175.0g)
were soaked in methanol at room temperature yielding a
greenish MeOH extract (55.0 g, 31.43 %). The MeOH
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extract (55.0 g) was further extracted with hexane to give
a hexane soluble extract (2.96 g, 5.33 %) and a hexane
insoluble residue. The hexane-insoluble residue was fur-
ther partitioned between chloroform-water (100 mL: 100
mL) to give a chloroform extract (11.85 g, 21.35 %) and
the aqueous layer was further partitioned with ethyl
acetate-water (100 mL: 100 mL) to give the ethyl acetate
extract (0.87g, 1.57 %) and H2O extract (30.08 g, 54.20 %).
The crude MeOH and fractionated extracts (hexane,
EtOAc and chloroform) were dissolved in dimethyl sulfox-
ide (DMSO) with the exception of the H2O extract which
was dissolved in distilled water to form stock solutions 20
mg/mL before testing. The final concentration of DMSO
in test wells was not in excess of 0.5 % (v/v).
Preparation of the chloroform extract without chlorophyll
Activated charcoal (1 teaspoon) was added to the
chloroform extract (20 mg) in 50 ml methanol and the
mixture was then mixed well. The mixture was immedi-
ately filtered with a filter paper (no. 1) to obtain the
chloroform extract without chlorophyll.
Cell culture
The human cell lines A549 (lung cancer) and Ca Ski
(cervical cancer) were cultured as monolayer in RPMI
1640 growth media whereas HCT-116 (colon cancer)
and MRC5 (human normal lung fibroblasts) was cultured
in McCoy’s 5A and EMEM medium, respectively. All cells
were purchased from the American Tissue Culture Col-
lection (ATCC, USA). All the media were supplemented
with 10 % v/v foetal bovine serum (FBS), 100 μg/mL peni-
cillin/streptomycin, and 50 μg/mL amphotericin B. The
cells were cultured in a 5 % CO2 incubator at 37 °C.
In vitro cytotoxicity screening
The monolayer cell culture was detached using accutase
and the cell count was adjusted to 2.5 x105 -3.0 x105
cells/mL using medium containing feotal bovine serum.
The cells were then plated into 96 wells with a cell dens-
ity of 5000-7000 cells/well and then incubated for 24 h
to allow adherence of cells to the base of well of the
plates. The media was then removed and 200 μl of fresh
media containing different concentration of various ex-
tracts or isolated compounds were added. Cisplatin was
used as the positive control. The plates were incubated
for 24, 48 and 72 h at 37 °C and 5 % CO2. The cytotox-
icity of the extracts and isolated compounds were
screened using the Sulphoramide B (SRB) assay. This
assay was first described by Houghton in 2007 [8]. The
incubation was halted by gentle addition of 50 μl ice
cold 4 % trichloroacetic acid (TCA) to each well and the
plates were incubated at 4 °C for 1 h. Then, the super-
natant was discarded and the plates were washed with
distilled water for 5 times and then air dried. SRB dye,
50 μl, (0.4 % w/v) was added into each well and the
treated cells and control were incubated at room
temperature for 30 min. The unbound dye was removed
by rapid washing four times with 1 % acetic acid. The
plates were then air dried and 100 μl of tris base (10
mM unbuffered, pH 10.5) was added and the plates were
shaken at 500 rpm for 5 min to solublize the bound SRB
stain. The plates were then read with an ELISA reader
(Synergy H1 Hybrid) at an absorbance of 492 nm.
Isolation of compounds in the chloroform extract (treated
with charcoal) using HPLC
The chloroform extract of R. angustifolia (treated with
charcoal) was repeatedly subjected to HPLC separation.
Treatment with charcoal was to remove chlorophyll that
might interfere with the separation process.
Analytical HPLC analysis was initially performed on an
Agilent 1260 infinity HPLC system consisting of a quater-
nary pump equipped with a 1260 autosampler (ALS), a
1290 thermostat, a 1260 thermostatted column compart-
ment (TCC), a 1260 diode array detector (DAD VL+), a
1260 fraction collector (FC-AS) and Agilent OpenLAB
CDS Chemstation for LC software. The analytical ana-
lysis was carried out using a binary eluent of chromato-
graphic grade acetonitrile (ACN) and ultrapure water
under the following gradient conditions: 0 to 20 min
isocratic 30 % ACN; 20 to 25 min linear gradient from
30 to 60 % ACN; 25 to 35 min linear gradient from 60
to 100 % ACN; 35 to 40 min isocratic 100 % ACN at a
flow rate of 1.0 ml/min. The column used was a ZOR-
BAX Eclipse XDB-C18 (4.6 × 250 mm, 5 μm) and the
temperature was set at 30 °C. The chloroform extract
of Ruta angustifolia was filtered with activated charcoal
to remove most of the chlorophyll and the filtrate was
evaporated to dryness using a rotary evaporator. The
extract was then prepared to a concentration of 5 mg/ml
with methanol and filtered through a membrane filter
(0.45 μm, Sartorius). The sample (5.0 μL) was injected onto
the column and peaks were detected by monitoring the
UV absorbance at 200 nm. Subsequently the sample was
prepared at 50 mg/ml in methanol and then 100 μl of the
sample was injected into the Agilent Semi Prep XDB-C18
column (9.4 × 250 mm, 5 μm) at a flow rate of 4.18 ml/
min. Selected peaks in the resulting chromatogram were
repeatedly collected using a fraction collector. Similar frac-
tions from each round of separation were combined and
the mobile phases were evaporated using a rotary evapor-
ator at 40 °C, and the fractions were weighed.
From the HPLC analysis, twenty peaks were ob-
served, and the eluents of the peaks were collected
and then pooled to give twenty fractions (1-20) based
on similarity of spots on TLC. Fractions that showed
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single spot on TLC were subjected to analytical
HPLC analysis for determination of purity.
Chemical characterization of compounds
All the compounds were identified through their mass
spectral and NMR data. Some of the compounds were
further confirmed by their Rf values from the TLC analysis
by comparison with authenticated compounds. TLC pre-
coated plates (silica gel 60F254) of 20-25 mm thickness
were used and a solvent system consisting of chloroform
with a few drops of methanol was used. Identification of
compounds using gas chromatography-mass spectrometry
(GCMS) was done using the Agilent Technologies 6980N
gas chromatography equippped with a 5979 mass selective
detector (70 eV direct inlet) was used. The column used
was HP-5MS (5 % phenylmethyl siloxane) capillary column
(30.0 mm × 25 mm × 25 μm) with helium as carrier gas at
flow rate of 1mL min-1. The column temperature was pro-
grammed initially at 100 °C, then increased to 300 °C,
at 3 °C per minute afterwhich the temperature was kept
isothermally for 10 min. The compounds were identified
by comparison of their mass spectral data with an accom-
panying mass spectral library NIST08 Spectral Library.
Morphological studies
Phase contrast microscopy
A549 cells were seeded at a density of 5000-7000 cells
into a tissue culture dish (6cm) and left overnight to
adhere. Then, the cells were treated with chalepin at
various concentrations for 24, 48, and 72 h at 37 °C and
5 % CO2. Changes in cytomorphology of the cells which
include shrinkage, detachment, rounding, spiking, bleb-
bing and formation of apoptotic bodies were observed
using phase contrast microscopy (Zeiss Axio Vert. A1).
Hoechst/PI fluorescent staining
This study was carried out to observe changes in cell nu-
cleus. 5000-7000 cells were seeded into each 6 cm cul-
ture dish and allowed to adhere overnight. The cells
were subsequently treated with various concentrations of
chalepin for 48 and 72 h. At the end of the incubation
period, the media in the culture dishes were discarded
and the cells were washed twice with PBS, after which
1mL of PBS was added to each culture dish. To stain the
cells with fluorescent dyes, 100 μ L of Hoechst solution
(100μ g/mL) and 25 μL of PI solution (100 μ g/mL) were
added to each culture dish and incubated for 15min. Fi-
nally, the cells were photographed using Leica DM-
16000B fluorescent microscope.
Apoptosis Detection by Annexin V-FITC/PI Staining
FITC annexin V apoptosis detection kit (BD) was used
to detect apoptosis. Cells were seeded in tissue culture
dishes (5000-7000 cells/dish) and allowed to adhere
overnight. Next, the cells were treated with various con-
centrations of chalepin for 48 and 72 h. The cells were
harvested, washed, and resuspended in 1x binding buffer
according to the manual provided in the kit. In the next
step, the cells were stained in the ratio of per 100,000
cells; staining of cells with 5 μL of FITC-annexin V and
5 μL of propidium iodide was done for 15 min. Then,
200 μL of 1× binding buffer was added to each sample.
Unstained and single-stained untreated cells were also
included as controls. A minimum number of 10,000
events was acquired for each replicate using Accuri C6
flow cytometer. A quadrant statistic was used to meas-
ure the population of viable, early apoptotic, late apop-
totic and secondary necrotic cells. The determination
betweent these different populations were obtained by
estimating quantitatively the cells that were AnnexinV/
PI stained.
DNA fragmentation measurement by TUNEL assay
DNA strand breaks in apoptotic cells caused by the acti-
vation of endonucleases, were detected by APO-BrdU
TUNEL assay kit. After incubation with various concen-
trations of chalepin at 48 and 72 h, cells were harvested
and washed with PBS. Next, the cells were fixed with 1 %
(w/v) paraformaldehyde for 15 mins, then washed with
PBS, and fixed with 70 % (v/v) ethanol overnight. Ethanol
was removed by centrifugation and DNA labeling steps
were performed according to the manual provided in the
kit. Samples were analyzed by flow cytometer and a mini-
mum of 10,000 events were acquired for each replicate.
Mitochondrial membrane potential assay
Flow cytometric analysis
A lipophilic and cell-permeable fluorochrome JC-1
(5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl benzimidazolyl
carbocyanine iodide), was used to measure mitochondrial
membrane potential (Δψm) according to the manufac-
turer’s instructions (BD MitoScreen Kit). The cells (1×106)
were seeded in tissue culture plates and were treated with
18, 27, 36, and 45 μg/ml of chalepin for 48 h incubation.
The cells were then harvested, washed with PBS twice and
incubated with JC-1 dye for 15 mins at 37°C. At the end
of the incubation, the cells were washed and resuspended
with 500 μl of 1x assay buffer (provided in the kit). The
intracellular fluorescence signals of JC-1 in the cells were
then measured with Accuri C6 flow cytometer. Approxi-
mately 10,000 events were recorded per analysis. In
healthy cells, JC-1 accumulates as aggregates in the mito-
chondria and emits red fluorescence. In cells, which have
undergone apoptosis, JC-1 remains in monomeric form in
the cytoplasm and emits green fluorescence. The red and
green fluorescence were detected at FL-2 and FL-1 chan-
nels respectively in the flow cytometer. Ratio of mean
fluorescence intensity between the FL1 and FL2 channels
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were calculated and this is used to determine the changes
in the mitochondrial membrane potential. The results
were analysed by calculating the ratio of JC-1 dimers to
JC-1 monomers. A higher ratio indicated a higher mem-
brane depolarization of mitochondria in cells (BD MitoSc-
reen Flow Cytometry Mitochondrial Membrane Potential
Detection Kit Instruction Manual). Cells that was un-
treated in 0.5 % DMSO acted as the control.
Fluorescence microscope imaging
JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl benzimidazo-
lyl carbocyanine iodide) mitochondrial membrane po-
tential assay kit by Abcam was used to stain the A549
cells to view the mitochondrial membrane potential
(Δψm) changes in cells. Prior to the JC-1 staining initi-
ation, 1x dilution buffer were prepared by adding 10 mL
10× dilution buffer to 90 mL deionized water. The solu-
tion was mixed gently and throughly. JC-1 stock (1mM)
was diluted to 20 μM working JC-1 solution. This was
done by adding 200 μl of JC-1 stock solution into 10 mL
of 1× dilution buffer. The cells (1×106) were seeded in
tissue culture plates and were treated with 18, 27, 36,
and 45 μg/ml of chalepin for 48 and 72 h incubation.
The cells were then harvested, washed with PBS twice
and incubated with JC-1 dye for 20 mins at 37 °C. At the
end of the incubation, the cells were washed and resus-
pended with 1000 μl of 1× dilution buffer. The cells
were viewed using a fluorescence microscope at an exci-
tation wavelength of Ex475 ± 20nm and emission wave-
length of Em530 ± 15 nm and 590 ± 17.5 nm. The
images were captured and recorded.
Intracellular Reactive Oxygen Species (ROS) measurement
The assay was conducted as described by Ling et al. [9]
with some minor modifications. The ROS measurement
was done using the fluorescent probe 2’,7’-dichlorofluor-
escein diacetate (DCFH-DA) that enabled the monitor-
ing of intracellular accumulation of ROS. The A549 cells
were seeded into a 96 well plate with a density of 2×104
cells per well and allowed to attach overnight. Treatment
with chalepin at various concentrations were done the
next day and incubated for different time periods. At the
end of the incubation period, the media was removed
and 5 μM of DCFH-DA which is diluted in media was
added to the cells and incubated for 40 min at 37 °C.
The cells were then washed three times with clear media
and the fluorescence intensity (excitation = 485 nm and
emission = 530 nm) was measured using a microplate
reader. The morphology of the cells were observed using
a fluorescence microscope.
Caspase-3 and Caspase-9 Activity
Caspase activity assays were performed according to the
instructions in the manual (CaspILLUME, Genetex).
Cells were seeded at a density of 1×106 cells per culture
dish. After being subjected to treatment for 48 and 72 h,
the cells were detached with accutase, washed, and resus-
pended in PBS. Next, 300 μL of each sample was aliquoted
into centrifuge tubes, after which 1 μL of fluorescent sub-
strate (FITC-DEVD-FMK for caspase 3 and FITC-LEHD-
FMK for caspase 9 activity) was added to each tube and
incubated for 1 h at 37°C incubator. At the end of the in-
cubation period, the cells were centrifuged at 3000 rpm
for 5 min and the supernatant was removed. After that,
the cells were resuspended in 0.5 mL wash buffer (pro-
vided in the kit) and centrifuged at 3000 rpm for 5 min.
This step was repeated before performing the analysis
with flow cytometer (Accuri C6) and a minimum of
10,000 events were acquired for each replicate.
Western blot analysis
For this analysis, 1× 105 of A549 cells were plated per
tissue culture dish. Chalepin treated whole-cell extracts
were lysed in lysis buffer (20 mM Tris (pH 7.4), 250 mM
NaCl, 2 mM EDTA (pH 8.0), 0.1 % Triton X-100, 0.01
mg/ml aprotinin, 0.005 mg/ml leupeptin, 0.4 mM PMSF,
and 4 mM NaVO4). Lysates were then spun at 15,000
rpm for 10 min to remove insoluble material and re-
solved on a 10.0 % SDS-PAGE gel. After electrophoresis,
the proteins were electrotransferred to a nitrocellulose
membrane, blocked with Blocking One (Nacalai Tesque,
Inc.), and probed with various antibodies (1:1000) over-
night at 4 °C. The blot was washed, exposed to HRP-
conjugated secondary antibodies for 1 h, and finally ex-
amined by chemiluminescence (ECL, Advansta).
Statistical analysis
All the values reported are shown as mean ± standard
error of the mean and all the experiments were con-
ducted at least twice using sample triplicates. Figures
from morphological studies, flow cytometry plots and
Western blot analyses are representative of the ex-
periment replicates. Comparison between control and
treated groups were performed using one-way ANOVA
with post hoc Tukey test (*p < 0.05 considered statistically
significant). Statistical analysis were performed using SPSS
20.0 software and calculations were done using the Micro-
soft Excel. Quantification of the bands in the western blot
analysis was done using the ImageJ software.
Results
Extraction, isolation of compounds and screening for
cytotoxicity
Extraction and fractionation was done on the leaves of
R. angustifolia. The yield of the methanol extract was
55.0 g which is 31.4 % of the total dried ground leaves.
The methanol extract was further partitioned with sol-
vents of different polarity. Water extract gave the highest
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yield followed by chloroform extract. Ethyl acetate ex-
tract had the lowest yield from methanol extract, as
compared to the other fractions. The percentage of the
fractionated extracts (hexane, chloroform, ethyl acetate
and water) were calculated based on the methanol ex-
tract (Table 1).
Cytotoxicity screenings of the crude and fractionated
extracts of R. angustifolia
Selected cancer cell lines (A549, Ca Ski and HCT-116)
were used in the screening of the crude and fractionated
extracts of R. angustifolia for their cytotoxic potency.
Toxicity towards normal cells were tested against MRC5
cell line. All the extracts showed no toxicity towards
MRC5 with an IC50 value of more than 100.00 μg/ml.
The chloroform extract (without chlorophyll), showed
slight toxicity with an IC50 value of 65.7 ± 0.5 μg/ml. It
was found that the activity of all the extracts were time
and concentration dependant in which the lowest IC50
value was observed when treatment was done over 72 h.
The methanol extract exhibited good cytotoxic activity
in all the cancer cell lines tested and without toxicity to
normal cells. The chloroform extract showed the highest
activity and the cytotoxicity was even better when
chlorophyll was removed; however it exhibited slight
toxicity to MRC5 cell. The chloroform extract without
chlorophyll exhibited the best cytotoxicity in A549 cell
line with an IC50 of 8.8 μg/ml; hence it was chosen as a
candidate for further isolation of the chemical compo-
nents (Table 2) (Fig. 1).
Chemical isolation of active compounds from the
chloroform extract (without chlorophyll) of R. angustifolia
The chloroform extract was subjected to isolation and
purification using HPLC. Fractions were repeatedly
collected using preparative HPLC method. The HPLC
profile of the chloroform extract was shown in Fig. 2.
Twenty fractions were collected and twelve com-
pounds were successfully identified using GCMS analyses.
The mass spectral data of the isolated compounds ob-
tained were found to be consistent with previous reports
[6, 7, 10–12]. The compounds which has been successfully
identified are graveoline (1), psoralen (3), kokusaginine
(4), methoxsalen (5), bergapten (7), arborinine (8),
moskachan B (9), chalepin (10), moskachan D (12), chale-
pensin (13), rutamarin (14) and neophytadiene (16). The
structures of these compounds are illustrated in Fig. 3.
Identification of chemical components
The compound graveoline, psoralen, kokusaginine,
methoxsalen, bergapten, arborinine, moskachan B, moska-
chan D, chalepensin, rutamarin and neophytadiene were
identified through their mass spectral data which were
found to be consistent with published data [6, 7, 10–12].
However chalepin was identified through its’ mass spectral
which were consistent with published data [12] and NMR
data. Some collected peaks of HPLC were not identified
due to insufficient amount. The following compounds
analysed were identified from their EI mass spectra by
their m/z values: Graveoline, colorless powder, EIMS m/z
(%), 279 ([M]+, 100), 251 ([M-CO]+, 92), 192 (22), 125
(25). The mass spectral data obtained was in agreement
with published data [6]. Psoralen, yellowish powder, EIMS
m/z (%), 186 ([M]+, 100), 158 ([M-CO]+, 65), 130 ([M-
CO-CO]+, 19) and 102 ([M-CO-CO-CO]+, 32). The mass
spectral data was in agreement with published data of
psoralen [6, 11]. Kokusaginine, white crystals, EIMS m/z
(%), 259 ([M]+, 100), 244 ([M-Me]+, 43), 216 ([M-Me-
CO]+, 15), 201 ([M-Me-CO-Me]+, 19), 186 ([201-Me]+,
25) and 173 ([186-CH]+, 16). The obtained mass spectral
data is in agreement with published data [6]. Methoxsalen,
yellowish oil, EIMS m/z (%), 216 ([M]+,100), 201 ([M-
Me]+, 35), 188 ([M-CO]+,14), 173 ([188-CO]+, 54) and
145 ([173-CO]+, 21). The data obtained was consistent
with the mass spectral data of methoxsalen from NIST
webbook. Bergapten, white powder, EIMS m/z (%), 216
([M]+, 100), 201 ([M-Me]+, 35), 188 ([M-CO]+, 15), 173
([M-Me-CO]+, 64) and 145 ([M-Me-CO-CO)]+, 21). The
data obtained was consistent with published data [12].
Arborinine, yellow crystal, EIMS m/z (%), 285 ([M]+, 66),
270 ([M-Me]+, 100), 242 ([M-Me-CO]+, 49). The mass
spectra was in agreement with published data [11].
Moskachan B, brownish oil, EIMS m/z (%), 220
([M]+, 21), 135 ([M-CH2CH2CH2COCH3]
+, 100). The
mass spectra was in agreement with published data [7].
Chalepin, white crystals, EIMS m/z (%), 314 ([M]+, 88),
299 ([M-Me]+, 100), 281 ([M-Me-H2O]
+, 34) and 255
([M-(CH3)2COH]
+. The mass spectral data in the present
study corresponds to the data reported in published data
[12]. The GCMS analysis of chalepin is shown in Fig. 4.
1H NMR data (600 MHz, CDCl3): δ 7.48 (1H, s, H-5), δ
7.20 (1H, s, H-4), δ 6.71 (1H, s, H-9), δ 6.17 (1H, dd, J
= 18.00, 12.00 Hz, H-2’), δ 5.09 (2H, overlapping dd, H-
3’), δ 4.72 (1H, dd, J = 12.00, 6.00 Hz, H-2), δ 3.21 (2H,
overlapping dd, J = 18.00, 12.00, 6.00 Hz, H-3), δ 1.47 (6H,
s, 4’,5’-CH3), δ 1.37 (3H, s, 3”-CH3), δ 1.23 (3H, s, 2”-CH3).
The 13C NMR data (600 MHz, CDCl3): δ 162.25 (C-9a), δ
160.21 (C-7), δ 154.64 (C-8a), δ 145.61 (C-2’), δ 138.09
Table 1 The yield of extracts of R. angustifolia L. Pers from 175.0
g of dried ground leaves




Ethyl Acetate 0.87 1.57
Water 30.08 54.20
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(C-5), δ 130.87 (C-6), δ 124.58 (C-3a), δ 123.26 (C-4), δ
113.14 (C-4a), δ 112.09 (C-3’), δ 97.14 (C-9), δ 90.91
(C-2), δ 71.70 (C-1”), δ 40.30 (C-1’), δ 29.61 (C-3), δ
26.11 (C-3”,4’,5’), δ 24.21 (C-2”). The NMR spectra of
isolated chalepin is shown in Fig. 5. Moskachan D,
yellowish oil, EIMS m/z (%), 248 ([M]+, 30), 148 ([M-
CH2-CH2-CH2-CH2-COCH3]





+, 11). The obtained
data is consistent with published data [7]. Chalepensin,
yellowish solid, EIMS m/z (%), 254 ([M]+, 100), 239 ([M-
CH3]
+, 95), 211 ([M-CH3-CH-CH3]
+, 70), 199 ([M-CH3-
CH-CH3-C]+, 85). The mass spectra is in agreement with
published data [6]. Rutamarin, colorless crystals, EIMS m/
z (%), 356 ([M]+, 8), 341 ([M-CH3]
+, 4), 296 ([M-CH3-
COO]+, 19), 281 ([M-CH3-COO-CH3]
+, 100), 253 ([M-
CH3-COO-CH3-CO]
+, 14). The mass spectral data is in
agreement with published data [6]. Neophytadiene, light
yellow oil, EIMS m/z (%), 278 ([M]+, 15), 137 (14), 123
(68), 109 (42), 95 (71), 82 (70) and 71 (100). The mass
spectral from GCMS analysis is identified through com-
parison with NIST MS Library data (Table 3).
The isolated compounds were tested for their cytotox-
icity effect against A549 human lung carcinoma cells
and the normal human lung fibroblasts MRC5 cells. Re-
sults showed that the cytotoxicity effect against A549
cell was dose and time dependent. Chalepin exhibited
the highest cytotoxicity against A549 cell line after 72 h
incubation with a IC50 value of 8.69 ± 2.43 μg/ml. It was
also mildly toxic to the normal cell line with a IC50 value
of 23.4 ± 0.6 μg/ml. Arborinine, chalepensin and also mos-
kachan D also exhibited promising cytotoxic property
against A549 cell line with IC50 values of 13.1 ± 0.06, 14.0
± 0.15 and 18.5 ± 0.65 μg/ml respectively. However, arbor-
inine and chalepensin showed moderate toxicity towards
MRC5 normal human lung fibroblast cell line with IC50
values of 20.8 ± 0.15 and 23.3 ± 0.55 μg/ml respectively.
Moskachan D was non-toxic towards normal cell with an
IC50 value of 90.8 ± 0.8 μg/ml. Other isolated compounds
showed no toxicity towards the normal cells with IC50
values ranging more than 50.0 μg/ml. The results are rep-
resented in Table 4.
Morphological changes induced by chalepin
Phase contrast microscopy studies
Morphological changes in the A549 cells treated with
different concentrations of chalepin were observed using
the inverted phase contrast microscope. Typical mor-
phological features of apoptosis such as plasma mem-
brane blebbing, cell vacuolisation, echinoid spiking,
chromatin condensation, formation of apoptotic bodies,
cell shrinkage, nuclear fragmentation and others were
observed. Untreated cells appeared to be thriving health-
ily in the culture. After 48 h of incubation, formation of
apoptotic bodies and cell vacuolisation were observed
whereas after 72 h, most of the cells were floating and
Table 2 In vitro cytotoxicity screening with SRB assay upon various extracts of Ruta angustifolia L. Pers against selected cell lines
Cell Line A549 CasKi HCT-116 MRC5
Extract Incubation time IC50 (μg/ml)
Methanol 72 7.02 ± 0.36 10.56 ± 0.09 14.3 ± 0.93 >100
48 51.2 ± 1.85 35.00 ± 1.13 49.9 ± 0.36 >100
24 85.60 ± 0.85 >100.0 14.3 ± 0.93 >100.0
Hexane 72 33.1 ± 1.667 41.20 ± 0.23 49.9 ± 0.36 >100.0
48 >100.0 >100.0 >100.0 >100.0
24 >100.0 >100.0 36.40 ± 2.01 >100.0
Chloroform 72 10.1 ± 0.35 9.38 ± 0.49 88.0 ± 2.65 >100.0
48 22.67 ± 4.31 29.00 ± 0.46 >100.0 >100.0
24 72.0 ± 0.5 >100.0 11.8 ± 0.1 >100.0
Ethyl Acetate 72 35.1 ± 1.00 18.10 ± 0.15 12.40 ± 0.85 >100.0
48 >100.0 46.00 ± 0.76 27.1 ± 0.21 >100.0
24 >100.0 >100.0 23.2 ± 0.42 >100.0
Water 72 73.9 ± 8.30 92.2 ± 2.58 >100.0 >100.0
48 >100 >100.0 >100.0 >100.0
24 >100 >100.0 >100.0 >100.0
Chloroform without chlorophyll 72 8.8 ± 0.32 13.9 ± 1.23 10.8 ± 0.7 65.7 ± 0.5
48 23.20 ± 0.90 22.1 ± 0.21 14.3 ± 0.45 >100.0
24 88.0 ± 0.5 >100.0 21.9 ± 0.46 >100.0
Tabulated values are mean ± standard deviation (SD) of three replicates
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there was a shrinkage and also decrease in the cell num-
ber. At 40× magnification, alteration in condensation of
chromatin and in shape of cells were observed (Fig. 6).
Hoesct 33342 and PI nuclear staining
The nuclear morphological changes after treatment with
chalepin at various concentrations were observed using
Hoesct 33342 and propidium iodide (PI) dye, and was
observed under a fluorescent microscope. The control
showed only low blue color. After treatment of chalepin
for 72 h at various concentrations, observation of cells
fluorescing bright blue colored nucleus was observed.
The higher the concentration of chalepin, the higher the
number of cells that emits a bright blue signal. In 40x
magnification, chromatin condensation and nuclear
cleavage were observed (Fig. 7).
Annexin V-FITC/PI apoptotic analysis
The phosphatidylserine (PS) exposure on the outer leaflet
of the plasma membrane is a hallmark of apoptosis.
Annexin V is a protein which has high affinity for PS. Thus
the binding of Annexin V to PS provides a very sentitive
Fig. 1 The percentage of inhibition of various extracts of Ruta angustifolia L. Pers against different cancer cell lines. a Graph shows the percentage
of inhibition of various extracts of Ruta angustifolia L. Pers against A549 cell line at a range of concentrations in 72 h of incubation. b Graph
shows the percentage of inhibition of various extracts of Ruta angustifolia L. Pers against Ca Ski cell line at a range of concentrations in 72 h of
incubation. c Graph shows the percentage of inhibition of various extracts of Ruta angustifolia L. Pers against HCT 116 cell line at a range of
concentrations in 72 h of incubation. The data expressed as mean ± S.D. of three independent replicates (n = 3)
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method for detecting cellular apoptosis. A population of
cells undergoing apoptosis may contain necrotic cells due
to their damaged plasma membrane. To distinguish be-
tween Annexin V positive apoptotic and necrotic cells, the
fluorescent dye propidium iodide was used. Membranes of
damaged cells are permeable to propidium iodide. Thus,
using Annexin V conjugated to FITC (a fluorescent dye)
enables apoptotic cells to be identified and quantified on
single cell basis by flow cytometry. In this study, it can be
observed that as the treatment concentration of chalepin
increased, the density plot showed increase in the cell
population at the lower right quadrant (Q1-LR) which
represents the early apoptotic cells and also subse-
quently towards the upper right quadrant (Q1-UR)
which represents population of late apoptotic/second-
ary necrotic cells. Comparison between 48 h and 72 h
showed that at longer incubation, the cell population
in early, late apoptosis/secondary necrosis (upper
right quadrant – Q1-UL) increased with dose. But the
highest increase was observed in the late apoptosis
quadrant represented by upper right quadrant in the
density plot. The untreated, control cells which stayed
at lower left quadrant (Q1-LL) showed low staining
with both annexin V and PI showing viable cells. The
total AnnexinV positive cells represents a total of
early and late apoptotic cells in A549 cells, shows an
increase in dose and time dependant manner. The
Annexin V positive cells showed an increase from
7.27 ± 0.16 % at 9 μg/ml to 20.6 ± 0.53 % at 45 μg/ml
of chalepin. The population of AnnexinV positive
cells observed was significantly higher after 72 h in-
cubation. These results are shown in Fig. 8.
DNA fragmentation induced by chalepin on A549 cell
DNA fragmentation is one of the main distinctive feature
of apoptosis. DNA fragmentation is activated by nucleases
which would degrade the nuclear DNA into fragments of
about 200 base pairs in length. This feature is measured
by using APO-BrDU TUNEL assay kit. In this study, cha-
lepin was treated at various concentrations and incubated
for 48 and 72 h to measure the ability to induce DNA
fragmentation. It was found that chalepin induces DNA
fragmentation in A549 cell in a dose and time dependent
manner (Fig. 9). DNA fragmentation is represented in the
density plot above with R3 representing percentage of cells
that has nuclear DNA fragmentation for treatment at 48 h
and 72 h. The cell population would move to the upper
region in the density plot when DNA fragmentation is la-
belled. Upper region in the density plot represents cells
with fragmented DNA. Based on the results obtained,
after 48 h incubation, the DNA fragmentation increased
from 1.0 ± 0.08 % for untreated control cells to 38.5 ± 0.70
% for cells treated with chalepin at 45 μg/ml. At 72 h, the
DNA fragmentation increased from 1.50 ± 0.35 % for un-
treated control cells to 73.50 ± 0.20 % at 36 μg/ml however
a drop was observed at 45 μg/ml to 66.50 ± 0.29 %. This
result indicates that upon treatment of chalepin, DNA
fragmentation is initiated in the cell by endonucleases
Fig. 2 High Performance Liquid Chromatography (HPLC) chromatogram of the chloroform extract (without chlorophyll) of Ruta angustifolia L. Pers
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to enable cells to undergo apoptosis. With increasing
concentration of treated chalepin, the percentage of
DNA fragmentation in the treated cells increases.
This trend is also true for higher incubation time.
The DNA fragmentation that occurs in the cells is
dependant on the concentration of chalepin and the
incubation hours.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (MMP) may be dis-
rupted during early apoptosis. The loss of MMP in A549
cells which were treated with various concentrations of
chalepin was observed using the JC-1 dye. During the
early stage of apoptosis, mitochondrial depolarisation oc-
curs and this enabled fluorescence of JC-1 to turn from
red aggregates to green monomers. Figure 10a showed
untreated control cell did not show any increase in green
monomer formation. Upon treatment with chalepin at
different concentrations, the percentage of green mono-
mer increases in cytoplasm (Fig. 10b). This shows that,
chalepin significantly induced reduction of mitochondrial
membrane potential in A549 cells in a concentration de-
pendant manner. Figure 10c shows that at 48 h incubation
time, the untreated cells gives red fluorescence which indi-
cates that there is high membrane potential in the mito-
chondrial membrane which enables the JC-1 dye to pass
through the mitochondrial membrane and form aggre-
gates which could give the red fluorescence. This shows
that the cells are healthy. As the cells are treated with cha-
lepin, there is increase in the presence of the green fluor-
escence as the concentration of chalepin treated is
increased. When a cell undergoes apoptosis, the mito-
chondrial membrane potential would drop and this would
inhibit the influx of JC-1 dye into mitochondria. It would
remain in its initial monomeric form at cytoplasm which
would give the green fluorescence that is observed in cells
Fig. 3 Structures of isolated compounds
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that were treated with high concentration of chalepin i.e.,
36 μg/ml and 45 μg/ml. This observation is similar at 72 h
incubation time with a difference of more fluorescence in-
tensity at higher treatment time. We observed that the
cells at 45 μg/ml treatment dosage at 72 h, almost all gives
a green fluorescence. This indicates that almost all the
cells that were observed is undergoing apoptosis.
The effect of chalepin in inititating the generation
of intracellular ROS in A549 cells was detected using
the DCFH-DA dye. Observation through fluorescent
a
b
Fig. 4 GCMS analysis of Chalepin (a) Total ion chromatogram (b) Mass spectrum
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ab
Fig. 5 NMR spectra of isolated chalepin. a Proton NMR spectra and b 13C NMR spectra
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microscope was done on lung carcinoma cells after
treatment of chalepin for 24 and 48 h showed an in-
crease in intensity of green fluorescence of DCF in a
dose and time dependant manner in (Fig. 11a). It was
observed that, as the concentration of chalepin that
was treated to the cells was increased, there was an
increase in the intensity of green fluorescence by the
DCFH-DA dye. This trend was also true for an
increase in the incubation time. The DCFH-DA is a
non-polar dye which would be converted into DCFH
by cellular esterases. DCFH is non-fluorescent but is
switched to fluorescent DCF when it is oxidized by
ROS in the cell. Hence, the qualitative imagining
showed that the increase in the intracellular ROS
content is dependant upon the concentration of chalepin
and also the incubation time of the treatment. Besides the
Table 3 Identified isolated chemical compounds using GC-MS
Peak No. Compounds Molecular weight Molecular formula Retention time (s)
1 Graveoline 279 C17H13NO3 39.22
2 Unidentified - - -
3 Psoralen 186 C11H6O3 18.46
4 Kokusaginine 259 C14H13NO4 29.98
5 Methoxsalen 216 C12H8O4 22.54
6 Unidentified - - -
7 Bergapten 216 C12H8O4 23.06
8 Arborinine 285 C16H15NO4 37.13
9 Moskachan B 220 C13H16O3 18.35
10 Chalepin 314 C19H22O4 33.26
11 Unidentified - - -
12 Moskachan D 248 C15H20O3 22.65
13 Chalepensin 254 C16H14O3 25.65
14 Rutamarin 356 C21H24O5 34.72
15 Unidentified - - -
16 Neophytadiene 278 C20H38 23.85
17 Unidentified - - -
18 Mixture of acids, Stigmasterol and Vitamin E - - -
19 9,12,15-octadecatrienoic acid, Vitamin E, γ-sitosterol - - -
20 12-docosenamide - - -
Table 4 IC50 value of isolated compounds against A549 cell lines at 48 and 72 h incubation and MRC5 cell line at 72 h treatment
Isolated
Compounds
IC50 in μg/ml (μM)
(A549) (MRC5)
48 h 72 h 72 h
Graveoline 76.3 ± 2.08 (273.5) 44.6 ± 0.47 (159.9) 69.7 ± 2.5 (249.8)
Kokusaginine 87.4 ± 7.08 (337.5) >100 (>386.1) 74.8 ± 0.82 (288.8)
Bergapten >100 (>463.0) 43.53 ± 1.81 (201.5) >100 (>463.0)
Moskachan B >100 (>454.5) >100 (>454.5) >100 (>454.5)
Moskachan D 77.5 ± 3.0 (312.5) 18.5 ± 0.65 (74.6) 90.8 ± 0.8 (366.1)
Chalepensin 30.5 ± 1.30 (120.1) 14.0 ± 0.15 (55.1) 23.3 ± 0.55 (91.7)
Rutamarin 56.3 ± 1.53 (158.1) 68.5 ± 3.06 (192.4) >100 (>281.0)
Arborinine 27.7 ± 0.26 (97.2) 13.1 ± 0.06 (46.0) 20.8 ± 0.15 (73.0)
Chalepin 28.3 ± 1.06 (90.1) 8.69 ± 2.43 (28.0) 23.4 ± 0.6 (74.5)
Neophytadiene 69.2 ± 1.06 (248.9) 68.00 ± 2.43 (244.6) 77.4 ± 0.98 (278.4)
Cisplatina - 24.5 ± 1.8 (81.67) >100 (>333.33)
aCisplatin was used as the positive standard reference. Tabulated values are mean ± standard deviation (SD) of three replicates
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qualitative imaging, the quantification of the intracellular
content of ROS by measurement of the fluorescence of
the DCF was also conducted. The fluorescence were then
calculated in the ratio of fold increase of the fluorescence
intensity in the treated cells as compared to the untreated
negative control cells. The fold increase of intracellular
ROS was calculated based on fluorescence value obtained
from microplate reader. It was observed that in compari-
son to the control, the treated cells showed a gradual in-
crease in the fold increase of intracellular ROS content
starting at 2 h up till 6 h. This increase was time and dose
dependant. However at 8 h, there was a drop in the fluor-
escent measurement of the treated cells (Fig. 11b). This
observation could be due to the reason where cell death
has commenced and thus there is a drop.
Caspase 9 is associated with the activation of the in-
trinsic mitochondrial mediated pathway. CaspILLUME
fluorescein active caspase-9 staining kit was used to
determine the caspase 9 activity in regards to the
treatment of chalepin in A549 cells. Cells with
activated caspase 9 would move to the right side (V1-
R) of the density plot. The results shows that there is
a remarkable increase in the caspase 9 activity of cells
treated with chalepin as compared to the control (Fig.
12). It was observed that after 48 h of incubation
period there is a five-fold increase in activation of
caspase 9 from 4.5 ± 0.35 % in untreated control to 22.57
± 0.21 % in cells treated with 45 μg/ml of chalepin (Fig.
12a). As for the 72 h incubation period, there was an in-
crease from 3.97 ± 0.15 % for untreated control cells to
33.5 ± 0.35 % for treated cells with 45 μg/ml of chale-
pin and this is a 8.44 fold increase (Fig. 12b). When
cells receive apoptotic stimuli, the mitochondria re-
leases cytochrome c which then binds to Apaf-1, to-
gether with dATP. The resultant complex recruits
caspase-9 leading to its activation. Activated caspase-9
cleaves downstream caspases such as caspase-3, -6 and -7
initiating the caspase cascade [13]. This results shows that
chalepin treated cells undergo apoptosis through the
mitochondrial pathway.
Fig. 6 Untreated control was compared with A549 cells treated at different doses and time. The morphological changes in the cells were
observed under phase-contrast microscopy at 10x and 40x magnification. a A549 cells treated with different concentrations of chalepin for 48 h
and observed at 10x magnification. b A549 cells treated with different concentrations of chalepin for 48 h and observed at 40x magnification. c
A549 cells treated with different concentrations of chalepin 72 h and observed at 10x magnification. d A549 cells treated with different concentra-
tions of chalepin for 72 h and observed at 40x magnification. Cells shrinkage, formation of echinoid spikes, vacuolisation, formation of apoptotic
bodies and rounding were observed clearly
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Caspase 3 is a downstream caspase signal also known
as the effector caspase. Upon activation of caspase 9, a
signal cascade results in an activation of caspase 3 which
in turn results in the hydrolysis of more than 100 target
protein that subsequently results in apoptosis. Defect in
caspase 3 activity results in cancer. In this study, it was
observed that A549 cells treated with chalepin induces
caspase 3 activation. CaspILLUME fluorescein active
caspase-3 staining kit was used and the cell population
was analysed using a flow cytometer. In the event of cas-
pase 3 activation, the cell population would move to the
right hand side (V1-R) of the density plot (Fig 13). It
is observed that after 48 h of incubation period there
is an increase of 2.83 ± 0.06 % for untreated control
to 26.40 ± 0.79 % for cells treated with 45 μg/ml of
chalepin and this is a 9.32 fold increase (Fig. 13a). As
for the 72 h incubation period, there was an increase
from 5.63 ± 0.21 % for untreated control cells to
49.07 ± 0.63 % for treated cells with 45 μg/ml of cha-
lepin and this is a 8.71 fold increase (Fig. 13b).
Caspase-3 is required for some typical characteristics
of apoptosis, and is crucial for apoptotic chromatin
condensation and DNA fragmentation in all cell
types. Caspase-3 is essential for certain processes as-
sociated with the dismantling of the cell and the for-
mation of apoptotic bodies, but it may also function
Fig. 7 Effects of chalepin at different concentrations on nuclear morphological changes of A549 cell line at 48 h and 72 h incubation. After the
incubation period, the cells were stained with Hoechst 33342 and PI and were examined with a fluorescent microscope under magnification of
400x to observe the chromatin condensation, nuclear fragmentation and cell shrinkage
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Fig. 8 (See legend on next page.)
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before or at the stage when commitment to loss of
cell viability is made [14]. Activation of caspase 3 in
chalepin treated A549 cells therefore is an evidence
that apoptosis has commenced.
Western blot analysis
Changes in the expression of proteins involved in regula-
tion of survival and cell death following chalepin treat-
ment were examined by Western Blot analysis. Activation
of caspase cascade would trigger proteolytic degradation
of PARP and DNA fragmentation by endonucleases, lead-
ing to apoptosis. The expression of PARP was studied in
A549 cells treated with chalepin at different incubation
time. It was observed that the quantity of PARP expressed
decreased with time. This shows that the level of PARP
decreased with time as shown by Fig. 14a.
The mitochondrial mediated pathway is also known as
BCL-2 regulated pathway. The balance of function be-
tween proapoptotic and antiapoptotic BCL-2 protein
family determines the fate of cells towards apoptosis
[15]. Studies have shown Bax, Bad, Bak promote the
release of cytochrome c, while bcl-2 and Bcl-XL delays
this response and promote cell survival. Bcl-2 family
members regulate the apoptotic response by controlling
the mitochondrial membrane permeabilization (MMP).
Depolarisation of MMP and the formation of MPT (mito-
chondrial permeability transition) pore is a result of the
tranlocation of Bax from mitochondria to cytosol [16].
Chalepin was found to downregulate anti-apoptotic
gene products such as Bcl-2, survivin, XIAP, Bcl-xl and
cFLIP as shown by Fig. 14b This clearly shows that it
downregulates proteins that play a vital role in the cell
survival and thus, induces apoptosis. An upregulation in
the expression of Bax was observed (Fig. 14c). There was
an upregulation in the expression of cytochrome c,
Fig. 14c, which shows that the cytochrome c moved out
of mitochondria to cytosol leading to an upregulation of
cytochrome c. All these factors promotes cell cytolysis
or cytostasis.
The cytochrome c release and binding with dATP and
Apaf-1 results in formation of apoptosome which recruits
and activates caspase-9. Activated caspase 9, results in ac-
tivation of effector caspases such as caspase-3/7. These ef-
fector caspases then initiates apoptosis events. Results
indicated that chalepin induces cleavage of procaspases 9
and 3 to the active cleaved form. Procaspase 9 showed a
downregulation which indicated cleavage of the protein to
an active form. Procaspase 3, also showed downregulation
which indicated an activation. This result is further
stregthened by detection of the cleaved caspase 3 which
showed an upregulation. All these results are illustrated in
Fig. 14d. This clearly indicates that the intrinsic pathway
which is mediated by the mitochondria is activated. These
results are consistent with earlier caspase 3 and caspase 9
activity determination using flow cytometer.
Discussions
This is the first report on the cytotoxic potential of
the methanol and chloroform extracts on the human
lung carcinoma (A549), human colon carcinoma
(HCT-116) and human cervical carcinoma (CaSki)
cells and also the human normal lung fibroblast
(MRC5). A crude extract is considered to possess in
vitro cytotoxicity if the IC50 value, at incubation time
between 48 and 72 h, is less than 20 μg/ml [17].
Among all the extracts, the chloroform extract (with-
out chlorophyll) exhibited the highest cytotoxic activ-
ity (IC50 value of 8.8 ± 0.32 μg/ml) and was thus
selected for further investigation. The chloroform ex-
tract (without chlorophyll) exhibited better cytotox-
icity than the total chloroform extract which could
possibly be due to the removal of some inactive com-
ponents by charcoal. Activated carbon was used as
the absorbing material to remove the chlorophyll
present in the extract, inevitably charcoal can also ab-
sorb other components besides chlorophyll.
The chloroform extract (without chlorophyll) was sub-
jected to chemical isolation using the HPLC. Twelve
(12) components were successfully isolated and were
sufficient in quantity for further cytotoxicity screening.
Among these compounds were graveoline, kokusaginine,
bergapten, moskachan B, moskachan D, chalepensin,
rutamarin, arborinine, chalepin and neophytadiene. Most
of the compounds fall into the class of alkaloids, furano-
coumarin and also dihydrofuranocoumarins. Arborinine,
graveoline, moskachan B and moskachan D are alkaloids.
Besides chalepin, moskachan D and arborinine showed
good cytotoxic effect against A549 cell line at 72 h incu-
bation with IC50 values of 18.5 ± 0.65 μg/ml and 13.1 ±
0.06 μg/ml respectively. A previous report showed that
(See figure on previous page.)
Fig. 8 Induction of early and late apoptosis by chalepin at various concentrations in A549 cell line. a shows the flow cytometric density plot of
Annexin V-FITC/PI staining in A549 cells when treated with different concentrations of chalepin (18.0-45.0 μg/ml) at 48 h incubation. b Shows the
flow cytometric density plot of Annexin V-FITC/PI staining in A549 cells when treated with different concentrations (18.0 - 45.0 μg/ml) at 72 h in-
cubation time. c The bar chart shows the total annexin V positive cells. d The bar charts shows the distribution of cells in viable, early apoptosis,
late apoptosis and secondary necrosis phase in 48 h incubation. e The bar charts shows the percentage of distribution of the treated cell popula-
tion in viable, early apoptosis, late apoptosis or secondary necrosis phase in 72 h incubation. Doxorubicin served as the positive control. The data
is expressed as mean ± S.D. from three replicates. Asterisks indicates significantly different value as compared to control (*p < 0.05)
Richardson et al. BMC Complementary and Alternative Medicine  (2016) 16:389 Page 17 of 27
Fig. 9 DNA fragmentation based on TUNEL assay on A549 cells treated with chalepin at various concentrations at 48 h and 72 h incubation. a R3
region in the dot plots obtained from flow cytometry represents TUNEL positive staining in which cells were stained with FITC-conjugated
anti-BrdU antibody which resulted from treatment of chalepin on A549 cells at 48 h incubation. b R3 region in the dot plots obtained from
flow cytometry represents TUNEL positive staining in which cells were stained with FITC-conjugated anti-BrdU antibody resulted from treatment
of chalepin on A549 cells at 72 h incubation. c Bar chart represents the percentage of TUNEL positive cells. Histograms are representative of three
separate experiments (n = 3). Asterisks indicate significantly different value from control (*p < 0.05)
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arborinine isolated from Ruta graveolens showed IC50
values of 1.84 μg/ml, 11.74 μg/ml and 12.95 μg/ml on
cervical carcinoma (HeLa), breast adenocarcinoma
(MCF-7) and skin epidermoid carcinoma (A431) re-
spectively [18]. Several alkaloids isolated from natural
herbs exhibit antiproliferative and antimetastasis effects
on various types of cancers both in vitro and in vivo. Al-
kaloids, such as camptothecin and vinblastine, have
already been successfully developed into anticancer drugs
[19]. Rutamarin and chalepin are furanocoumarins and
it was reported that coumarins are the most abundant
in Rutaceae and Umbelliferae family [20]. Bergapten, a
furanocoumarin, exhibited mild cytotoxicity with an IC50
value of 43.53 ± 1.81 μg/ml against A549, human lung car-
cinoma cell line. Chalepin exhibited excellent cytotoxocity
activity (IC50 value of 8.69 ± 2.43 μg/ml) whereas ruta-
marin exhibited mild cytotoxicity (IC50 value of 68.5 ±
3.06 μg/ml). Rutamarin is the acetylated form of chalepin.
A previous report [21] showed that rutamarin had an IC50
value of 1.318 μg/ml against A549 cell line. The reason for
the lower activity of rutamarin in our hands, may be due
to crystallisation in the media at higher concentration of
rutamarin. Based on all the collective results, chalepin was
selected for further investigation.
Cells undergoing apoptosis show typical, well-defined
morphological changes which includes plasma membrane
blebbing, chromatin condensation with margination of
chromatin to the nuclear membrane, karyorhexis (nuclear
fragmentation), and formation of apoptotic bodies [22].
The morphological changes of A549 cells treated with
various concentrations of chalepin were observed using a
phase contrast microscope (Fig. 6). Observation showed
decrease in number of cells as the treatment concentra-
tion was increased at a magnification of 100×. Formation
of apoptotic bodies, vacuolisation, nuclear condensation,
echinoid spikes were visible at higher magnification
Fig. 10 a Dot plots obtained from flow cytometer shows the attenuation of mitochondrial membrane potential (MMP) in A549 cells treated with
chalepin at various concentrations and incubated at 48 h. b Bar chart represents the percentage of JC-1 that remained as green monomer which
shows the apoptotic cells with compromised mitochondrial membrane potential upon treatment of chalepin in dose dependent manner. The
data expressed as mean ± S.D from triplicates in experiment. Asterisks indicates significantly different value from control (*p < 0.05). c Effects of
chalepin at different concentrations on mitochondrial membrane potential changes of A549 cell line at 48 h and 72 h treatment time. After the
incubation period, the cells were stained with JC-1 dye and were examined with a fluorescent microscope under magnification of 630x to observe
whether the JC-1 aggregates in mitochondria (healthy cells) or JC-1 remains in monomer form at cytoplasm (apoptotic cells)
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(400×). Longer incubation period shows bigger change in
the morphology of the cells. In contrast, the untreated
control cells maintained a healthy structure and exponen-
tially increased with time.
Early, late apoptosis or secondary necrosis, and necro-
sis were visualised using Hoechst 33342 and propidium
iodide double staining assay. Hoechst 33342 dye can
cross the nuclear membrane to tag the nucleus.
Propidium iodide does not possess this capacity and
could only cross compromised nuclear membrane to
give a red staining. Nuclear membrane compromisation
is a characteristic of late apoptosis or necrosis and this
property could distinguish the cells undergoing early
apoptosis or late apoptosis or necrosis. In primary ne-
crosis, cytoplasmic swelling occurs and plasma mem-
brane ruptures together with organelle breakdown but
Fig. 11 Elevation of the intracellular reactive oxygen species (ROS) level was observed qualitatively through observation of the cells after incubating
with DCFH-DA dye and examining the changes using a fluorescent microscope and quantified using a fluorescence plate reader. a Induction of ROS
in A549 cells treated with chalepin at various concentrations and incubated for 24 h and 48 h b Bar chart represents the fold increase of intracellular
ROS level in A549 cells treated with different concentrations of chalepin as compared to untreated negative control cells. The data expressed as mean
± S.D. from three replicates. Asterisks indicates significantly different value from control (*p < 0.05)
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notably absence of nuclear fragmentation [23]. The low
blue fluorescence represents viable cells, bright blue
fluorescence represents cells undergoing early apoptosis,
pink or red fluorescence with fragmented nuclear DNA
represents cells at late apoptosis or secondary necrosis
and red fluorescence with intact nucleus represents cells
undergoing primary necrosis. The A549 cells treated
with chalepin primarily showed bright blue fluorescence
and the intensity of the fluorescence increased as treat-
ment concentration of chalepin is increased. At higher
concentraion and incubation time, pink or red fluores-
cence with fragmented DNA were observed (Fig. 7). An
Fig. 12 Caspase 9 activity of A549 cells treated with various concentrations of chalepin and incubated for 48 h and 72 h incubation. a Flow
cytometric analysis of apoptotic (V1-R) and non-apoptotic populations (V1-L) for active caspase 9 activity for untreated A549 cells and A549 cells
treated with chalepin at various concentrations for 48 h. b Flow cytometric analysis of apoptotic (V1-R) and non-apoptotic populations (V1-L) for
active caspase 9 activity for untreated A549 cells and A549 cells treated with chalepin at various concentrations for 72 h. c Bar chart representing
a comparison of fold increase between chalepin treated A549 cells at different incubation times (48 & 72 h). The data expressed as mean ± S.D. of
three replicates. Asterisks indicates significantly different value from control (*p < 0.05)
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apoptotic event in vivo, ends with phagocytosis by
phagocytes to remove the apoptotic bodies. However, in
in vitro conditions where the phagocytes are absent, the
cells that initially were in early apoptotic phase would
transform to late apoptotic or secondary necrotic phase
which is visualized by pink or red fluorescence with frag-
mented nuclei and this was observed at chalepin treat-
ment of 45 μg/ml at both 48 and 72 h incubation. This
Fig. 13 Caspase 3 activity of A549 cells treated with various concentrations of chalepin and incubated for 48 h and 72 h. a Flow cytometric
analysis of apoptotic (V1-R) and non-apoptotic populations (V1-L) for active caspase 3 activity for untreated A549 cells and A549 cells treated with
chalepin at various concentrations for 48 h. b Flow cytometric analysis of apoptotic (V1-R) and non-apoptotic populations (V1-L) for active caspase
3 activity for untreated A549 cells and A549 cells treated with chalepin at various concentrations for 72 h. c Bar chart representing the fold in-
crease of caspase 3 activity in A549 cells treated with chalepin at various concentrations as compared to untreated control cells. d Bar chart repre-
senting a comparison of fold increase between chalepin treated A549 cells at different incubation times (48 & 72 h). The data expressed as mean
± S.D. of three replicates. Asterisks indicates significantly different value from control (*p < 0.05)
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could be an indication that at higher concentration of
chalepin, the apoptosis cell death progresses faster. The
primary necrotic cells are usually stained red but with
uncompromised nucleus. The morphological studies
gives a preliminary insight on the morphological changes
and the type of death the cell undergoes upon treament
with chalepin.
Several biochemical criteria characterize apoptosis.
These include phophatidylserine (PS) exposure on the
outer leaflet of plasma membrane, changes in mitochon-
drial membrane permeability, release of intermembrane
space mitochondrial proteins and caspase-dependent ac-
tivation and nuclear translocation of a caspase activated
DNAse resulting in DNA cleavage and fragmentation
[22]. Expression of cell surface markers results in the
early phagocytic recognition of apoptotic cells by adja-
cent cells, thus permitting quick phagocytosis with min-
imal compromise to the surrounding tissue. Flow
cytometric Annexin V-FITC/PI double staining analysis
can be used to determine early apoptosis and to
distinguish between apoptotic and necrotic cells. In this
study, we observed that the Annexin V positive cells
which is the collective cells at the phase of early and late
apoptosis increased with the increase of treatment con-
centration of chalepin and the treatment time. This
clearly shows that chalepin has apoptosis inducing prop-
erty. DNA fragmentation was observed in the TUNEL
assay. Chalepin treated A549 cells also exhibited DNA
fragmentation in a concentration and time dependent
manner as shown in Fig. 9. DNA fragmentation is a hall-
mark of apoptosis. The tightly controlled activation of
the apoptosis-specific endonucleases provides an effect-
ive means to ensure the removal of unwanted DNA and
the timely completion of apoptosis [23]. DNA which
breaks exposes large amount of 3’-OH ends and this can
serve as the starting point for terminal deoxynucleotidyl
transferase (TdT) to add deoxyribonucleotides in a tem-
plate independent manner. Addition of the deoxythymi-
dine analog 5-bromo-2’-deoxyuridine 5’triphosphate
(BrdUTP) to the TdT reaction acts to label the break sites.
Fig. 14 Western blot analysis of whole cell protein lysate of A549 cells treated with chalepin at concentration of (36 μg/ml) at 2,4,8,12, and 24 h.
a Cleavage of PARP and upregulation of p53 tumor supressor factor, induced by chalepin.b Chalepin (36 μg/ml) inhibits anti-apoptotic gene
products. c Chalepin induces Bax and bak expression and cytochrome c release. d Chalepin activates cleavage of procaspase 9 and procaspase 3
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BrdU is then detected by an anti-BrdU antibody using im-
munohistochemical techniques.
Reactive oxygen species (ROS) are widely generated in
biological systems. Due to this, humans have evolved
antioxidant defence systems that limit their production.
Intracellular production of reactive oxygen species such
as •OH, O2
- and H2O2 is associated with the arrest of cell
proliferation. Similarly, generation of oxidative stress in
response to various external stimuli has been implicated
in the activation of transcription factors and to the trig-
gering of apoptosis [24]. It was described that ROS and
the mitochondria plays a major role in apoptosis induc-
tion under both physiologic and pathologic conditions
[25]. Interestingly, mitochondria are both source and
target of ROS. In our experiment, we have observed that
there was an increase in the intracellular ROS level upon
treatment with chalepin concentration and time depend-
ently (Fig. 11). The increase was significantly higher as
compared to control for up to 6 h of incubation with cha-
lepin but a sharp drop was noticed after 8 h. This could
be due to the fact that after 8 h the A549 cells started to
die. Our experiment is designed such that ROS is only
measured in viable cells as the dye used could only stain
viable cells. A sharp decrease in the ROS content after 8 h
shows that cell death commences after 6 h of incuba-
tion. The highest ROS fold increase was observed up
to 62.24 fold at 45 μg/ml chalepin with 6 h incuba-
tion. ROS promotes outer membrane permeabilization
and mitochondria-to-cytosol translocation of cytochrome
c, AIF or Smac/Diablo and triggers the caspase cascade.
Thus, ROS stimulates apoptotic pathway [26]. Irrespective
of the morphological features of end-stage cell death (that
may be apoptotic, necrotic, autophagic, or mitotic), mito-
chondrial membrane permeabilization (MMP) is fre-
quently the decisive event that determines the survival
and death of a cell [27]. The treatment of chalepin on
A549 cells at 48 h incubation showed an increase in the
reduction of mitochondrial membrane potential in a dose
dependent manner (Fig. 10). This shows that chalepin in-
duces disruption in the mitochondrial membrane poten-
tial. Depolarisation of the mitochondrial membrane often
leads to the release of cytochrome c into the cytoplasm.
Caspases (cysteinyl aspartate-specific proteases) are
synthesized as dormant proenzymes that, upon proteo-
lytic activation, acquire the ability to cleave key intracel-
lular substrates, resulting in the morphological and
biochemical changes associated with apoptosis [28]. The
caspase 9 activity was observed initially based on the
analysis of cell population in a flow cytometer. The re-
sults showed that the caspase 9 activity was activated in
A549 cells treated with chalepin in a concentration and
time dependent manner. Caspase-9 is a member of the
caspase family of cysteine proteases that have been im-
plicated in apoptosis and cytokine processing. When
cells receive apoptotic stimuli, the mitochondria releases
cytochrome c which then binds to Apaf-1, together with
dATP. The resultant complex recruits caspase-9 leading
to its activation. Activated caspase-9 cleaves downstream
caspases such as caspase-3, -6 and -7 initiating the cas-
pase cascade [13]. Our results show that caspase 9 was
Fig. 15 Graphical summarization of the action of chalepin in inducing mitochondrial mediated apoptosis in A549 cancer cell lines
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activated which led to the downstream effector and the
downstream effector caspase cascade. Caspase 3 or bet-
ter known as the effector caspase is the caspase that ex-
ecutes the order received from caspase 9 to initiate
apoptosis physically. In our preliminary analysis caspase
3 was activated in the A549 cells treated with chalepin
in a concentration and also time dependent manner
(Fig. 13). Caspase-3 is a frequently activated death pro-
tease, catalyzing the specific cleavage of many key cellu-
lar proteins [14] which eventually will result in DNA
fragmentation as illustrated by the results from the
TUNEL assay.
The mitochondria play an important role in coordinat-
ing caspase activation through the release of cytochrome
c [28]. The mitochondrial-mediated pathway is also
known as BCL-2 regulated pathway, intrinsic pathway
and stress-induced pathway [14]. Western blot tech-
nique was employed to study the regulation expression
of apoptotis related proteins. The Bcl-2 family members
determine the liberation of mitochondrial protein [15].
Apoptotic threshold is set by interactions on the mito-
chondrial outer membrane between three functionally
and structurally distinct subgroups of the BCL‐2 protein
family: BH3 (the BCL‐2 homology 3) proteins (which
convey signals to initiate apoptosis), the pro‐survival cell
guardians such as BCL‐2 itself, and the pro‐apoptotic ef-
fector proteins BAX (BCL‐2‐associated X protein) and
BAK (BCL‐2 antagonist/killer). Thus, this family can be
regarded as a tripartite apoptotic switch. When enough
BH3‐only proteins have been stimulated in response to
various cytotoxic stresses to exceed the apoptotic thresh-
old, BAX and/or BAK begin to oligomerize to a pore
that permeabilize the mitochondrial outer membrane.
This releases apoptogenic factors into the cytosol, par-
ticularly cytochrome c, which promotes the activation of
procaspase 9 on APAF1; activated caspase 9 in turn pro-
cesses and activates the effector caspases i.e., caspase 3
[15]. In the western blot analysis, it was observed that
the Bcl-2 protein and Bcl-XL, pro-survival cell proteins
which also inhibit apoptosis, was downregulated in a
time dependent manner (0,2,4,8,12,24 h). Bax and Bak
was upregulated time dependently and this shows that
the promoter of apoptosis is upregulated.
p53, is a critical tumor suppressor. It functions to in-
duce apoptosis as a result of DNA damage, hypoxia and
oncogenic activation. Various biological functions such
as cell cycle arrest, angiogenesis, senescence, metasta-
sis, metabolism, and autophagy is associated to p53
[29]. In this study, upon treatment with chalepin, it was
observed that there was an upregulation in the expres-
sion of p53 in Fig. 14(a). Bax is directly activated by the
p53 tumor suppressor proteins following stress induc-
tion or indirectly through the p53-activation of the Bcl-
2 pro-apoptotic member Noxa and PUMA, or throught
the p53-independant mechanisms. The downregulation
of Bcl-2 is necessary to prevent it blocking Bax
oligomerization. Formation of the Bax pore, as well as
the loss of mitochondrial potential causes cytochrome c
to leak out of the mitochondria to cytosol [30]. We ob-
served an increase in the level of cytochrome c in a
time dependent manner. Cytochrome c would in turn
activate the cleavage of procaspase 9 which is the initi-
ator caspase, in which we observe in our study with a
downregulation of the protein as time increases. Cas-
pase 9 would inititate a signal cascade of caspases in
which caspase 3 which is the effector caspase is acti-
vated. In this study it was observed that, procaspase 3
was downregulated which indicates the activation of
procaspase 3 and an upregulation in the cleaved cas-
pase. Inhibitor of apoptosis (IAP) proteins works in
multiple ways in cell death regulation, ranging from in-
hibition of apoptosis and necrosis to the regulation of
cell cycle and inflammation. Due to their ability to con-
trol cell death and elevated expression in a variety of
cancer cell types, IAP proteins are attractive targets for
the development of novel anti-cancer treatments [31].
Some of the inhibitor of apoptosis such as survivin,
XIAP, cFLIP, Bcl-2, Bcl-xl were found to be downregu-
lated which allows apoptosis to proceed.
Conclusion
In conclusion, this is the first report on the cytotoxic ef-
fect of chalepin isolated from R.angustifolia L.Pers
against A549 cell line by induction of apoptosis. Apop-
tosis was found to be mediated by the mitochondria
through Bax and Bak upregulation, The downregulation
of inhibitor of apoptosis such as Bcl-2, survivin, Bcl-xl
and cFLIP downregulation and release of cytochrome c
and activation of caspases 9 and 3 to induce apoptosis.
Chalepin was also found to exert DNA fragmentation
and PS externalisation in A549 cells treated with it. This
compound could be an excellent candidate to be consid-
ered as a therapeutic agent. This research is summarized
graphically as in Fig. 15.
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